Conference Coverage

Ischemic mitral regurgitation: valve repair vs. replacement

Publish date: January 30, 2016

 

EXPERT ANALYSIS FROM THE CARDIOVASCULAR CONFERENCE AT SNOWMASS

References

Dr. Mack reported receiving research grants from Abbott Vascular, which is sponsoring the COAPT trial, as well as from Edwards Lifesciences.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Should annular dilation be a marker for concomitant tricuspid valve repair?
MDedge Surgery
Six-year Norwood-RVPA results in matched patients outperformed BT-shunt
MDedge Surgery
Aortic valve replacement: Transcatheter soars past surgical
MDedge Surgery
3D imaging tracks causes of post-TAVR aortic regurgitation
MDedge Surgery
Post-repair MR may be worse than thought
MDedge Surgery
Off-pump bypass may confer stroke benefit
MDedge Surgery
Finding more transplant hearts but not more donors
MDedge Surgery
STS: Score stratifies risks for isolated tricuspid valve surgery patients
MDedge Surgery
VIDEO: Shorter gap from heart attack to CABG shown safe
MDedge Surgery
VIDEO: U.S. TAVR growth continues, mostly among octogenarians
MDedge Surgery